Peritransplant Renal Dysfunction in Liver Transplant Candidates


  • Renal failure in cirrhosis.

    N Engl J Med. 2009; 361: 1279-1290

    • Fede G.
    • D’Amico G.
    • Arvaniti V.
    • et al.

    Renal failure and cirrhosis: a systematic review of mortality and prognosis.

    J Hepatol. 2012; 56: 810-818

    • Chauhan K.
    • Azzi Y.
    • Faddoul G.
    • et al.

    Pre-liver transplant renal dysfunction and association with post-transplant end-stage renal disease: a single-center examination of updated UNOS recommendations.

    Clin Transplant. 2018; 32: e13428

    • Ojo A.O.
    • Held P.J.
    • Port F.K.
    • et al.

    Chronic renal failure after transplantation of a nonrenal organ.

    N Engl J Med. 2003; 349: 931-940

    • Saliba F.
    • Fischer L.
    • de Simone P.
    • et al.

    Association between renal dysfunction and major adverse cardiac events after liver transplantation: evidence from an international randomized trial of everolimus-based immunosuppression.

    Ann Transplant. 2018; 23: 751-757

    • Shenoy S.
    • Hardinger K.L.
    • Crippin J.
    • et al.

    Sirolimus conversion in liver transplant recipients with renal dysfunction: a prospective, randomized, single-center trial.

    Transplantation. 2007; 83: 1389-1392

    • Pawarode A.
    • Fine D.M.
    • Thuluvath P.J.

    Independent risk factors and natural history of renal dysfunction in liver transplant recipients.

    Liver Transpl. 2003; 9: 741-747

    • Cabezuelo J.B.
    • Ramírez P.
    • Ríos A.
    • et al.

    Risk factors of acute renal failure after liver transplantation.

    Kidney Int. 2006; 69: 1073-1080

    • Wong F.
    • Nadim M.K.
    • Kellum J.A.
    • et al.

    Working party proposal for a revised classification system of renal dysfunction in patients with cirrhosis.

    Gut. 2011; 60: 702-709

    • Gleisner A.L.
    • Jung H.
    • Lentine K.L.
    • et al.

    Renal dysfunction in liver transplant candidates: evaluation, classification and management in contemporary practice.

    J Nephrol Ther. 2012; ()https://doi.org/10.4172/2161-0959.S4-006

    • Hampel H.
    • Bynum G.D.
    • Zamora E.
    • et al.

    Risk factors for the development of renal dysfunction in hospitalized patients with cirrhosis.

    Am J Gastroenterol. 2001; 96: 2206-2210

    • Martín-Llahí M.
    • Guevara M.
    • Torre A.
    • et al.

    Prognostic importance of the cause of renal failure in patients with cirrhosis.

    Gastroenterology. 2011; 140: 488-496.e4

    • Moore K.P.
    • Wong F.
    • Gines P.
    • et al.

    The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club.

    Hepatol. 2003; 38: 258-266

    • Platt J.F.
    • Ellis J.H.
    • Rubin J.M.
    • et al.

    Renal duplex Doppler ultrasonography: a noninvasive predictor of kidney dysfunction and hepatorenal failure in liver disease.

    Hepatology. 1994; 20: 362-369

    • Fernández J.
    • Navasa M.
    • Garcia-Pagan J.C.
    • et al.

    Effect of intravenous albumin on systemic and hepatic hemodynamics and vasoactive neurohormonal systems in patients with cirrhosis and spontaneous bacterial peritonitis.

    J Hepatol. 2004; 41: 384-390

    • Salerno F.
    • Gerbes A.
    • Ginès P.
    • et al.

    Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis.

    Postgrad Med J. 2008; 84: 662-670

    • Wong F.
    • Pappas S.C.
    • Curry M.P.
    • et al.

    Terlipressin plus albumin for the treatment of type 1 hepatorenal syndrome.

    N Engl J Med. 2021; 384: 818-828

    • Skagen C.
    • Einstein M.
    • Lucey M.R.
    • et al.

    Combination treatment with octreotide, midodrine, and albumin improves survival in patients with type 1 and type 2 hepatorenal syndrome.

    J Clin Gastroenterol. 2009; 43: 680-685

    • Heda R.
    • Yazawa M.
    • Shi M.
    • et al.

    Non-alcoholic fatty liver and chronic kidney disease: retrospect, introspect, and prospect.

    World J Gastroenterol. 2021; 27: 1864-1882

    • Platt J.F.
    • Marn C.S.
    • Baliga P.K.
    • et al.

    Renal dysfunction in hepatic disease: early identification with renal duplex Doppler US in patients who undergo liver transplantation.

    Radiology. 1992; 183: 801-806

    • Gerbes A.L.
    • Gülberg V.
    • Bilzer M.
    • et al.

    Evaluation of serum cystatin C concentration as a marker of renal function in patients with cirrhosis of the liver.

    Gut. 2002; 50: 106-110

    • Mindikoglu A.L.
    • Dowling T.C.
    • Weir M.R.
    • et al.

    Performance of chronic kidney disease epidemiology collaboration creatinine-cystatin C equation for estimating kidney function in cirrhosis.

    Hepatol. 2014; 59: 1532-1542

    • Sampaio M.S.
    • Martin P.
    • Bunnapradist S.

    Renal dysfunction in end-stage liver disease and post-liver transplant.

    Clin Liver Dis. 2014; 18: 543-560

    • Singapura P.
    • Ma T.W.
    • Sarmast N.
    • et al.

    Estimating glomerular filtration rate in cirrhosis using creatinine-based and cystatin C-based equations: systematic review and meta-analysis.

    Liver Transpl. 2021; 27: 1538-1552

    • Fagundes C.
    • Pépin M.N.
    • Guevara M.
    • et al.

    Urinary neutrophil gelatinase-associated lipocalin as biomarker in the differential diagnosis of impairment of kidney function in cirrhosis.

    J Hepatol. 2012; 57: 267-273

    • Verna E.C.
    • Brown R.S.
    • Farrand E.
    • et al.

    Urinary neutrophil gelatinase-associated lipocalin predicts mortality and identifies acute kidney injury in cirrhosis.

    Dig Dis Sci. 2012; 57: 2362-2370

    • Belcher J.M.
    • Sanyal A.J.
    • Peixoto A.J.
    • et al.

    Kidney biomarkers and differential diagnosis of patients with cirrhosis and acute kidney injury.

    Hepatol Aug. 2014; 60: 622-632

    • Gomaa S.H.
    • Shamseya M.M.
    • Madkour M.A.

    Clinical utility of urinary neutrophil gelatinase-associated lipocalin and serum cystatin C in a cohort of liver cirrhosis patients with renal dysfunction: a challenge in the diagnosis of hepatorenal syndrome.

    Eur J Gastroenterol Hepatol. 2019; 31: 692-702

    • Singal A.K.
    • Ong S.
    • Satapathy S.K.
    • et al.

    Simultaneous liver kidney transplantation.

    Transplant Int. 2019; 32: 343-352

    • Singal A.K.
    • Hasanin M.
    • Kaif M.
    • et al.

    Nonalcoholic steatohepatitis is the most rapidly growing indication for simultaneous liver kidney transplantation in the United States.

    Transplant. 2016; 100: 607-612

    • Molnar M.Z.
    • Joglekar K.
    • Jiang Y.
    • et al.

    Association of pretransplant renal function with liver graft and patient survival after liver transplantation in patients with nonalcoholic steatohepatitis.

    Liver Transplant. 2019; 25: 399-410

    • Yu J.W.
    • Gupta G.
    • Kang L.
    • et al.

    Obesity does not significantly impact outcomes following simultaneous liver kidney transplantation: review of the UNOS database – a retrospective study.

    Transplant Int. 2019; 32: 206-217

    • Nadim M.K.
    • Annanthapanyasut W.
    • Matsuoka L.
    • et al.

    Intraoperative hemodialysis during liver transplantation: a decade of experience.

    Liver Transplant. 2014; 20: 756-764

    • Zimmerman M.A.
    • Selim M.
    • Kim J.
    • et al.

    Outcome analysis of continuous intraoperative renal replacement therapy in the highest acuity liver transplant recipients: a single-center experience.

    Surgery. 2017; 161: 1279-1286

    • Baek S.D.
    • Jang M.
    • Kim W.
    • et al.

    Benefits of intraoperative continuous renal replacement therapy during liver transplantation in patients with renal dysfunction.

    Transplant Proc. 2017; 49: 1344-1350

    • Cabezuelo J.B.
    • Ramirez P.
    • Acosta F.
    • et al.

    Does the standard vs piggyback surgical technique affect the development of early acute renal failure after orthotopic liver transplantation?.

    Transplant Proc. 2003; 35: 1913-1914

    • Barbas A.S.
    • Levy J.
    • Mulvihill M.S.
    • et al.

    Liver transplantation without venovenous bypass: does surgical approach matter?.

    Transplant Direct. 2018; 4: e348

    • Sun K.
    • Hong F.
    • Wang Y.
    • et al.

    Venovenous bypass is associated with a lower incidence of acute kidney injury after liver transplantation in patients with compromised pretransplant renal function.

    Anesth Analg. 2017; 125: 1463-1470

    • Cohen A.J.
    • Stegall M.D.
    • Rosen C.B.
    • et al.

    Chronic renal dysfunction late after liver transplantation.

    Liver Transpl. 2002; 8: 916-921

    • Fisher N.C.
    • Nightingale P.G.
    • Gunson B.K.
    • et al.

    Chronic renal failure following liver transplantation: a retrospective analysis.

    Transplantation. 1998; 66: 59-66

    • Gonwa T.A.
    • Mai M.L.
    • Melton L.B.
    • et al.

    End-stage renal disease (ESRD) after orthotopic liver transplantation (OLTX) using calcineurin-based immunotherapy: risk of development and treatment.

    Transplantation. 2001; 72: 1934-1939

    • Lynn M.
    • Abreo K.
    • Zibari G.
    • et al.

    End-stage renal disease in liver transplants.

    Clin Transplant. 2001; 15: 66-69

    • Davis C.L.
    • Gonwa T.A.
    • Wilkinson A.H.

    Pathophysiology of renal disease associated with liver disorders: implications for liver transplantation. Part I.

    Liver Transplant. 2002; 8: 91-109

    • Campistol J.M.
    • Sacks S.H.

    Mechanisms of nephrotoxicity.

    Transplantation. 2000; 69: Ss5-Ss10

    • Olyaei A.J.
    • de Mattos A.M.
    • Bennett W.M.

    Immunosuppressant-induced nephropathy: pathophysiology, incidence and management.

    Drug Saf. 1999; 21: 471-488

  • Loss of glomerular function and tubulointerstitial fibrosis: cause or effect?.

    Kidney Int. 1994; 45: 345-351

    • Lin M.
    • Mittal S.
    • Sahebjam F.
    • et al.

    Everolimus with early withdrawal or reduced-dose calcineurin inhibitors improves renal function in liver transplant recipients: a systematic review and meta-analysis.

    Clin Transplant. 2017; 31https://doi.org/10.1111/ctr.12872

    • Lange N.W.
    • Salerno D.M.
    • Sammons C.M.
    • et al.

    Delayed calcineurin inhibitor introduction and renal outcomes in liver transplant recipients receiving basiliximab induction.

    Clin Transplant. 2018; 32: e13415

    • Boyd A.
    • Brown A.
    • Patel J.
    • et al.

    Basiliximab with delayed tacrolimus improves short-term renal outcomes post-liver transplantation-a real-world experience.

    Transplant Proc. 2021; 53: 1541-1547

    • Best L.M.
    • Leung J.
    • Freeman S.C.
    • et al.

    Induction immunosuppression in adults undergoing liver transplantation: a network meta-analysis.

    Cochrane Database Syst Rev. 2020; 1: Cd013203

    • Biancofiore G.
    • Della Rocca G.
    • Bindi L.
    • et al.

    Use of fenoldopam to control renal dysfunction early after liver transplantation.

    Liver Transplant. 2004; 10: 986-992

    • Gillies M.A.
    • Kakar V.
    • Parker R.J.
    • et al.

    Fenoldopam to prevent acute kidney injury after major surgery-a systematic review and meta-analysis.

    Crit Care. 2015; 19: 449

    • Rocca G.D.
    • Pompei L.
    • Costa M.G.
    • et al.

    Fenoldopam mesylate and renal function in patients undergoing liver transplantation: a randomized, controlled pilot trial.

    Anesth Analg. 2004; 99: 1604-1609

    • Swärd K.
    • Valsson F.
    • Odencrants P.
    • et al.

    Recombinant human atrial natriuretic peptide in ischemic acute renal failure: a randomized placebo-controlled trial.

    Crit Care Med. 2004; 32: 1310-1315

    • Köttgen A.
    • Selvin E.
    • Stevens L.A.
    • et al.

    Serum cystatin C in the United States: the third national health and nutrition examination survey (NHANES III).

    Am J Kidney Dis. 2008; 51: 385-394

  • Dopazo, C., Charco, R., Caralt, M., Pando, E., Lázaro, J. L., Gómez-Gavara, C., Castells, L., & Bilbao, I. (2018). Low Total Dose of Anti-Human T-Lymphocyte Globulin (ATG) Guarantees a Good Glomerular Filtration Rate after Liver Transplant in Recipients with Pretransplant Renal Dysfunction. Can J Gastroenterol Hepatol 2018.



  • Source link
    #Peritransplant #Renal #Dysfunction #Liver #Transplant #Candidates

    Leave a Reply

    This site uses Akismet to reduce spam. Learn how your comment data is processed.

    %d bloggers like this: